T‐cell response to structural and nonstructural hepatitis C virus antigens in persistent and self‐limited hepatitis C virus infections
暂无分享,去创建一个
C. Ferrari | A. Penna | T. Giuberti | L. Galati | F. Fiaccadori | M. Marin | A. Valli | Patrizia Scaccaglia | C. Schianchi | Gabriale Missale
[1] C. Ferrari,et al. Long-term follow-up of anti-hepatitis C virus antibodies in patients with acute nonA nonB hepatitis and different outcome of liver disease. , 2008, Liver.
[2] M. Houghton,et al. T-lymphocyte response to hepatitis C virus in different clinical courses of infection. , 1993, Gastroenterology.
[3] B. Walker,et al. Intrahepatic cytotoxic T lymphocytes specific for hepatitis C virus in persons with chronic hepatitis. , 1992, Journal of immunology.
[4] M. Puoti,et al. Hepatitis C virus RNA and antibody response in the clinical course of acute hepatitis C virus infection , 1992, Hepatology.
[5] R. Ahmed,et al. Immunological memory against viruses. , 1992, Seminars in immunology.
[6] G. Nemo,et al. HEPATITIS C VIRUS INFECTION IN POST-TRANSFUSION HEPATITIS - AN ANALYSIS WITH FIRST - AND SECOND - GENERATION ASSAYS , 1991 .
[7] M. Houghton,et al. Molecular biology of the hepatitis C viruses: Implications for diagnosis, development and control of viral disease , 1991, Hepatology.
[8] F. Chisari,et al. Identification of immunodominant T cell epitopes of the hepatitis B virus nucleocapsid antigen. , 1991, The Journal of clinical investigation.
[9] A. Alberti,et al. Antibody to hepatitis C virus in post-transfusion hepatitis. , 1991, Annals of internal medicine.
[10] M. Houghton,et al. Confirmation of hepatitis C virus infection by new four-antigen recombinant immunoblot assay , 1991, The Lancet.
[11] H. Margolis,et al. Risk factors for acute non-A, non-B hepatitis in the United States and association with hepatitis C virus infection. , 1990, JAMA.
[12] H J Alter,et al. An assay for circulating antibodies to a major etiologic virus of human non-A, non-B hepatitis. , 1990, Science.
[13] M. Houghton,et al. Detection of antibody against antigen expressed by molecularly cloned hepatitis C virus cDNA: application to diagnosis and blood screening for posttransfusion hepatitis. , 1990, Proceedings of the National Academy of Sciences of the United States of America.
[14] R. Purcell,et al. Detection of antibody to hepatitis C virus in prospectively followed transfusion recipients with acute and chronic non-A, non-B hepatitis. , 1989, The New England journal of medicine.
[15] M. Houghton,et al. PREVALENCE OF ANTIBODIES TO HEPATITIS C VIRUS IN ITALIAN PATIENTS WITH HEPATOCELLULAR CARCINOMA , 1989, The Lancet.
[16] D. Sansonno,et al. ANTIBODIES TO HEPATITIS C VIRUS IN NON-A, NON-B POST-TRANSFUSION AND CRYPTOGENETIC CHRONIC LIVER DISEASE , 1989, The Lancet.
[17] M. Buti,et al. HEPATITIS C VIRUS ANTIBODIES AMONG RISK GROUPS IN SPAIN , 1989, The Lancet.
[18] M. Houghton,et al. ANTI-HEPATITIS C ANTIBODIES AND NON-A, NON-B POST-TRANSFUSION HEPATITIS IN THE NETHERLANDS , 1989, The Lancet.
[19] M. Houghton,et al. Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome. , 1989, Science.
[20] Jules L. Dienstag,et al. An assay for circulating antibodies to a major etiologic virus of human non-A, non-B hepatitis , 1989 .
[21] R. Deitch. How Generous Has This Government Really Been to the NHS? , 1984, The Lancet.
[22] A. Saxon,et al. Single step separation of human T and B cells using AET treated srbc rosettes. , 1976, Journal of immunological methods.
[23] Williams Jt,et al. ROYAL COLLEGE OF PHYSICIANS. THE NEW BUILDING. , 1964, Lancet.
[24] S. Lemon,et al. Viral Hepatitis and Liver Disease , 1994, Springer Japan.
[25] H. Blum,et al. Long-term follow-up of posttransfusion and sporadic chronic hepatitis non-A, non-B and frequency of circulating antibodies to hepatitis C virus (HCV). , 1990, Journal of hepatology.
[26] M. Houghton,et al. Hepatitis C virus: the major causative agent of viral non-A, non-B hepatitis. , 1990, British medical bulletin.
[27] G. B. Thornton,et al. Antibody production to the nucleocapsid and envelope of the hepatitis B virus primed by a single synthetic T cell site , 1987, Nature.
[28] C. Taswell. Limiting Dilution Assays for the Separation, Characterization, and Quantitation of Biologically Active Particles and Their Clonal Progeny , 1987 .